Home » Blog

Announcement: Recent News from the Web

Articles from the Internet are regularly gleaned from the website and posted. An attempt is made to categorize them, as listed in the sidebar on the right. Click on the Categories widget to see the categories, and select the category of interest. They will appear on a new page in order from the most recent to the oldest. Some are from refereed scientific journals, while other are from more popular press websites. Almost all posts include a very brief description with a link to the actual article. As always, be careful about the source.

Video: “Prostate Cancer Genetics: Where are we now?”

March 2019 Awareness Night Prostate Cancer Genetics: Where are we now? Justin Lorentz  MSc, CGC Cancer Genetic Counsellor Lead,Male Oncology Research and Education (MORE) Dept of Radiation Oncology, Sunnybrook Odette Cancer Centre     CLICK ON THE ARROW TO START THE VIDEO The Complete Presentation 41:24 minutes 

Newsletter March 2019

Awareness: The PCCN-Toronto and Side by Side Prostate Cancer Support Groups Newsletter. In this Issue: Do It For Dads Walk/Run on Father’s Day – Sunday June 16, 2019 Sponsors back again in 2019 – Thank you Miscellaneous Notes Our next Awareness Night – May 2019 PCCN-Toronto celebrating our 25th year including a bit of history PCC celebrating 25 years in 2019 Ask the Health Care Team – “Prostate cancer and prostate enlargement (BPH) – what’s the connection” by Dr. Sharon Sharir (Humber River Regional Hospital) Our 2019 Awareness Nights lineup On going projects Read it by clicking the link below …

Newsletter March 2019 Read More »

Age-related risks of radical prostatectomy

It will hardly come as a surprise to most prostate cancer support group leaders and other prostate cancer advocates that there is a strong association between patient age and risk for side effects of radical prostatectomy. However, we now have a rather more sophisticated set of insight into such risks. Read the article.

Active Surveillance for Intermediate Risk Prostate Cancer: Survival Outcomes in the Sunnybrook Experience.

Data from the survival outcomes of patients support the use of active surveillance in low risk and intermediate risk cases of Gleason 6 but not Gleason 7 prostate cancer. Multiparametric magnetic resonance imaging and novel biomarkers might be vital in detecting favorable Gleason 7 disease. Read the article here.

Scroll to Top